Comprehensive Cognitive Support for Focus, Working Memory, and Mental Energy*
What It Does
Advanced NeuroPlus Clinical Nootropic delivers a research-backed blend of nootropic nutrients and adaptogens designed to support attention, working memory, mental performance, and neural resilience.* Featuring clinically studied doses of branded ingredients such as Neumentix™, Cognizin®, and NeuroFactor™ (Cognatiq), this formula is designed for individuals seeking comprehensive brain health support.*
How It Works
• Neumentix™ Spearmint Extract (900 mg): Standardized to 24% total phenolics and 14.5% rosmarinic acid; shown to improve working memory, sustained attention, and reactive agility in both younger and older adults without negatively affecting sleep.*[1-3]
• Cognizin® Citicoline (500 mg): Supports acetylcholine and phosphatidylcholine synthesis; enhances brain energy metabolism, memory performance, and attention across adult and adolescent populations.*[4-6]
• NeuroFactor™ (Cognatiq) Coffee Fruit Extract (200 mg): Increases levels of brain-derived neurotrophic factor (BDNF), supporting cognitive performance and neural health.*[7-8]
• Lion’s Mane Mushroom (600 mg): Contains neuroactive compounds such as hericenones and erinacines; supports nerve growth factor (NGF) production, mood, and memory function.*[9-11]
• American Ginseng Extract (200 mg): A source of neuroprotective ginsenosides; supports working memory, attentional processing, and prefrontal brain activity.*[12-15]
• Acetyl L-Carnitine (500 mg): Provides acetyl groups for neurotransmitter synthesis and mitochondrial energy production; supports NGF signaling and antioxidant activity.*[16-22]
Who It’s For
Ideal for students, professionals, and adults of all ages seeking stimulant-free, research-informed support for working memory, attention, and cognitive stamina.*
Special Features
Advanced NeuroPlus Clinical Nootropic combines six clinically relevant brain-supportive ingredients.* It delivers broad cognitive support for mental clarity, focus, and long-term neuroprotection.*
References
1. Falcone PH, et al. Nutr Res. 2019;64:24–38. doi:10.1016/j.nutres.2018.11.012
2. Fonseca B, et al. Neurology. 2015;84(14_suppl). doi:10.1212/wnl.84.14_supplement.p7.105
3. Falcone PH, et al. J Int Soc Sports Nutr. 2018;15(1):58. doi:10.1186/s12970-018-0264-5
4. Nakazaki E, et al. J Nutr. 2021;151(8):2153–60.
5. McGlade E, et al. J Atten Disord. 2019;23(2):121–34.
6. McGlade EC, et al. Food Nutr Sci. 2012;3:769–73
7. Reyes-Izquierdo T, et al. Br J Nutr. 2013;110(3):420–5.
8. Robinson JL, et al. Antioxidants (Basel). 2021;10(2):144. doi:10.3390/antiox10020144
9. Nagano M, et al. Biomed Res. 2010;31(4):231–7.
10. Martínez-Mármol R, et al. bioRxiv. 2020;2008:271676
11. Nagano M, et al. Biomed Res. 2010;31(4):231–7
12. Shin K, et al. Regul Toxicol Pharmacol. 2016;78:53–8.
13. Scholey A, et al. Psychopharmacology (Berl). 2010;212(3):345–56.
14. Ossoukhova A, et al. Hum Psychopharmacol. 2015;30(2):108–22.
15. White DJ, et al. Hum Psychopharmacol. 2020;35(6):1–6.
16. Traina G. Front Biosci. 2016;21(7):1314–29.
17. Xu S, et al. Magn Reson Med. 2015;74(6):1530–42.
18. Zidan A, et al. Biomed Pharmacother. 2018;103:1302–11.
19. Abdul HM, et al. J Neurosci Res. 2006;84(2):398–408.
20. Yang SP, et al. Mol Med Rep. 2015;12(1):1145–50.
21. Chiechio S, et al. Curr Neuropharmacol. 2006;4(3):233–7.
